Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Project

Therapeutic application of SAMMSON lncRNA inhibition in ocular melanoma and non-melanoma tumors

Outputs & Impact

Publications & research data ( 1 )

mTOR inhibition enhances delivery and activity of antisense oligonucleotides in uveal melanoma cells

Shanna DewaeleLouis DelhayeBoel De PaepeBram BogaertRamiro MartinezJasper AnckaertNurten YigitJustine NuytensRudy Van CosterSven Eyckerman et al.

A1 Journal Article in NUCLEIC ACID THERAPEUTICS

Activities ( 0 )

Results

Impact narratives ( 0 )

Combinations of therapeutic agents for treating uveal melanoma

Patent application(s)

WO2020239685 ( 02 December 2020 )

Inhibition of a lncRNA for treatment of melanoma

Patent application(s)

WO2015024986 ( 25 February 2015 )

Granted patent(s)

USRE048801 ( 01 November 2021 )